307 related articles for article (PubMed ID: 30081037)
21. PLD3 epigenetic changes in the hippocampus of Alzheimer's disease.
Blanco-Luquin I; Altuna M; Sánchez-Ruiz de Gordoa J; Urdánoz-Casado A; Roldán M; Cámara M; Zelaya V; Erro ME; Echavarri C; Mendioroz M
Clin Epigenetics; 2018 Sep; 10(1):116. PubMed ID: 30208929
[TBL] [Abstract][Full Text] [Related]
22. Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease.
Sung HY; Choi BO; Jeong JH; Kong KA; Hwang J; Ahn JH
PLoS One; 2016; 11(4):e0153156. PubMed ID: 27058954
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
[TBL] [Abstract][Full Text] [Related]
24. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease.
Glöckner F; Meske V; Ohm TG
Neuroscience; 2002; 114(4):1103-14. PubMed ID: 12379263
[TBL] [Abstract][Full Text] [Related]
25. Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.
Xie B; Xu Y; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
J Alzheimers Dis; 2017; 56(1):391-401. PubMed ID: 27935556
[TBL] [Abstract][Full Text] [Related]
26. TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.
Mise A; Yoshino Y; Yamazaki K; Ozaki Y; Sao T; Yoshida T; Mori T; Mori Y; Ochi S; Iga JI; Ueno SI
J Alzheimers Dis; 2017; 60(3):1107-1117. PubMed ID: 28984592
[TBL] [Abstract][Full Text] [Related]
27. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
[TBL] [Abstract][Full Text] [Related]
28. CRTC1 gene is differentially methylated in the human hippocampus in Alzheimer's disease.
Mendioroz M; Celarain N; Altuna M; Sánchez-Ruiz de Gordoa J; Zelaya MV; Roldán M; Rubio I; Larumbe R; Erro ME; Méndez I; Echávarri C
Alzheimers Res Ther; 2016 Apr; 8(1):15. PubMed ID: 27094739
[TBL] [Abstract][Full Text] [Related]
29. Neurofilament-labeled pyramidal neurons and astrocytes are deficient in DNA methylation marks in Alzheimer's disease.
Phipps AJ; Vickers JC; Taberlay PC; Woodhouse A
Neurobiol Aging; 2016 Sep; 45():30-42. PubMed ID: 27459923
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent.
Beffert U; Cohn JS; Petit-Turcotte C; Tremblay M; Aumont N; Ramassamy C; Davignon J; Poirier J
Brain Res; 1999 Oct; 843(1-2):87-94. PubMed ID: 10528114
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease.
Huang Y; Weisgraber KH; Mucke L; Mahley RW
J Mol Neurosci; 2004; 23(3):189-204. PubMed ID: 15181247
[TBL] [Abstract][Full Text] [Related]
32. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
33. Methylation analysis of SST and SSTR4 promoters in the neocortex of Alzheimer's disease patients.
Grosser C; Neumann L; Horsthemke B; Zeschnigk M; van de Nes J
Neurosci Lett; 2014 Apr; 566():241-6. PubMed ID: 24602981
[TBL] [Abstract][Full Text] [Related]
34. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
35. High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease.
Yamagata K; Urakami K; Ikeda K; Ji Y; Adachi Y; Arai H; Sasaki H; Sato K; Nakashima K
Dement Geriatr Cogn Disord; 2001; 12(2):57-62. PubMed ID: 11173875
[TBL] [Abstract][Full Text] [Related]
36. Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer's disease.
Semick SA; Bharadwaj RA; Collado-Torres L; Tao R; Shin JH; Deep-Soboslay A; Weiss JR; Weinberger DR; Hyde TM; Kleinman JE; Jaffe AE; Mattay VS
Acta Neuropathol; 2019 Apr; 137(4):557-569. PubMed ID: 30712078
[TBL] [Abstract][Full Text] [Related]
37. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.
Lambert JC; Araria-Goumidi L; Myllykangas L; Ellis C; Wang JC; Bullido MJ; Harris JM; Artiga MJ; Hernandez D; Kwon JM; Frigard B; Petersen RC; Cumming AM; Pasquier F; Sastre I; Tienari PJ; Frank A; Sulkava R; Morris JC; St Clair D; Mann DM; Wavrant-DeVrièze F; Ezquerra-Trabalon M; Amouyel P; Hardy J; Haltia M; Valdivieso F; Goate AM; Pérez-Tur J; Lendon CL; Chartier-Harlin MC
Neurology; 2002 Jul; 59(1):59-66. PubMed ID: 12105308
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease.
Yamada T; Kondo A; Takamatsu J; Tateishi J; Goto I
J Neurol Sci; 1995 Mar; 129(1):56-61. PubMed ID: 7751846
[TBL] [Abstract][Full Text] [Related]
39. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.
Lambert JC; Berr C; Pasquier F; Delacourte A; Frigard B; Cottel D; Pérez-Tur J; Mouroux V; Mohr M; Cécyre D; Galasko D; Lendon C; Poirier J; Hardy J; Mann D; Amouyel P; Chartier-Harlin MC
Hum Mol Genet; 1998 Sep; 7(9):1511-6. PubMed ID: 9700208
[TBL] [Abstract][Full Text] [Related]
40. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.
Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y
J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
